Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01263821 · ClinicalTrials.gov registry record · NA
Image Guided Therapy in the Treatment of Gliomas
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01263821: Clinical Trial NA study, sponsored by NYU Langone Health.
NCT01263821 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01263821, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
RATIONALE: New imaging techniques using magnetic resonance imaging give better tumor definition, thus may lead to better tumor targeting and avoid damaging critical parts of normal brain. PURPOSE: This phase I/II trial is studying how well image-guided therapy works in treating patients with newly diagnosed intracranial glioma.
Interventions
- PROCEDURE Functional magnetic resonance imaging
- PROCEDURE Diffusion-weighted magnetic resonance imaging
- PROCEDURE Therapeutic conventional surgery
- PROCEDURE Perfusion-weighted magnetic resonance imaging
- PROCEDURE Magnetic resonance spectroscopic imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-08 |
| Est. Completion | 2014-04 |
| Phase | NA |
Why NCT01263821 stopped before completion
NCT01263821 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Functional magnetic resonance imaging is the first listed.
NCT01263821 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01263821 about?
NCT01263821 is a clinical study titled "Image Guided Therapy in the Treatment of Gliomas". RATIONALE: New imaging techniques using magnetic resonance imaging give better tumor definition, thus may lead to better tumor targeting and avoid damaging critical parts of normal brain. PURPOSE: This phase I/II trial is studying how well image-guided therapy works in treating patients with newly ...
What is the current status of trial NCT01263821?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2009-08. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01263821?
The interventions under investigation include: Functional magnetic resonance imaging (PROCEDURE), Diffusion-weighted magnetic resonance imaging (PROCEDURE), Therapeutic conventional surgery (PROCEDURE), Perfusion-weighted magnetic resonance imaging (PROCEDURE), Magnetic resonance spectroscopic imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01263821?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01263821's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia